The association between serum lipid profile and the prostate cancer risk and aggressiveness

Purpose This study aims to evaluate the association of serum lipid profile on prostate cancer (PC) risk and aggressiveness. Methods Men who underwent prostate biopsy between January 2005 and December 2015 were retrospectively analyzed. The association between lipid profile and the risk, stage, and Gleason grade group (GG) of the PC were investigated. Sensitivity analysis was conducted using univariate and multivariate quantile analysis for lipide profile on the risk and stage of PC. Results Of the 1740 study populations, 720 men (41.4%) were diagnosed as PC. From multivariate logistic regression analysis, age, prostate specific antigen, triglyceride (odds ratio (OR):1.05, confidence interval (CI):1.03-1.07, p-value<0.001) significantly increased PC risk, while total cholesterol (OR:0.96, CI:0.92-0.99, p-value=0.011) significantly decreased the PC risk. The increase of serum triglyceride increased the risk of both of locally advanced (OR:1.03, CI:1.00-1.07, p-value=0.025) and metastatic PC (OR:1.14, CI:1.04-1.25, p-value=0.004). The increase of serum triglyceride increased the risk of GG2-3 (OR:1.03, CI:1.00-1.06, p-value=0.027) and GG4-5 (OR:1.04, CI:1.01-1.08, p-value=0.027). Univariate quartile analysis founded serum triglyceride increasing risk of locally advanced disease than organ confined disease. (OR: 1.00, 1.25, 2.04, 4.57 for 1st, 2nd, 3rd and 4th quartile, p-value<0.001). Adjusted multivariate quartile analysis confirmed statistically significant increasing PC risk of triglyceride (OR: 1.00, 1.25, 2.04, 4.57 for 1st, 2nd, 3rd and 4th quartile, p-value<0.001). Conclusions This study findings suggested increased in triglyceride level increased the risk PC. Increased in triglyceride level also associated with aggressive presentation of PC, with higher stage and GG.

[1]  Julio M. Pow‐Sang,et al.  Management of Patients With Nonmetastatic Prostate Cancer , 2022, Journal of the National Comprehensive Cancer Network.

[2]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[3]  Natalia Scaglia,et al.  Prostate Cancer Progression: as a Matter of Fats , 2021, Frontiers in Oncology.

[4]  G. Norata,et al.  Global epidemiology of dyslipidaemias , 2021, Nature Reviews Cardiology.

[5]  G. Lee,et al.  Associations of Serum Lipid Level with Gastric Cancer Risk, Pathology, and Prognosis , 2020, Cancer research and treatment : official journal of Korean Cancer Association.

[6]  Jacob D. Jaffe,et al.  High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program , 2019, Nature Communications.

[7]  M. Loda,et al.  Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer , 2018, Proceedings of the National Academy of Sciences.

[8]  S. Egawa,et al.  Epidemiology of prostate cancer in Asian countries , 2018, International journal of urology : official journal of the Japanese Urological Association.

[9]  S. Serni,et al.  Meta-analysis of metabolic syndrome and prostate cancer , 2017, Prostate Cancer and Prostatic Diseases.

[10]  M. Wirth,et al.  Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study , 2016, Prostate Cancer and Prostatic Diseases.

[11]  L. Butler,et al.  Androgen control of lipid metabolism in prostate cancer: novel insights and future applications. , 2016, Endocrine-related cancer.

[12]  H. Brenner,et al.  Blood lipids and prostate cancer: a Mendelian randomization analysis , 2016, Cancer medicine.

[13]  Mats Lambe,et al.  Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories , 2016, Cancer medicine.

[14]  Choung-Soo Kim,et al.  Epidemiology of prostate cancer in South Korea , 2015, Prostate international.

[15]  L. Pengfei,et al.  Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[16]  M. Terris,et al.  Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[17]  A. Kural,et al.  Prostate cancer in Asia: A collaborative report , 2014, Asian journal of urology.

[18]  Yong Q. Chen,et al.  Lipids and prostate cancer. , 2012, Prostaglandins & other lipid mediators.

[19]  Edward Giovannucci,et al.  The correlation between metabolic syndrome and prostatic diseases. , 2012, European urology.

[20]  L. Holmberg,et al.  Prostate cancer risk in the Swedish AMORIS study , 2011, Cancer.

[21]  Stephen L. Abrams,et al.  Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging , 2011, Aging.

[22]  J. Klenk,et al.  Serum triglyceride concentrations and cancer risk in a large cohort study in Austria , 2009, British Journal of Cancer.

[23]  K. Nakajima,et al.  Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor. , 2009, Cancer epidemiology.

[24]  Shou-En Lu,et al.  Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. , 2007, Cancer control : journal of the Moffitt Cancer Center.

[25]  Jayoung Kim,et al.  Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. , 2005, The Journal of clinical investigation.

[26]  T. Hansen,et al.  A common polymorphism in the promoter of the IGF-I gene associates with increased fasting serum triglyceride levels in glucose-tolerant subjects. , 2004, Clinical biochemistry.

[27]  M. Loda,et al.  The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. , 2004, Cancer cell.

[28]  R. Vessella,et al.  Increased AKT Activity Contributes to Prostate Cancer Progression by Dramatically Accelerating Prostate Tumor Growth and Diminishing p27Kip1 Expression* , 2000, The Journal of Biological Chemistry.

[29]  P. Malone,et al.  Prostate , 1995 .

[30]  G. Mcclearn,et al.  Genetic and environmental influences on serum lipid levels in twins. , 1993, The New England journal of medicine.